Arrow Mark Colorado Holdings LLC Rhythm Pharmaceuticals, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $10.6 Million - $13.9 Million	-543,990 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $145,552 - $191,594	7,817 Added 1.46%	543,990 $11.7 Million
Q2 2019 Aug 14, 2019	SELL	$21.11 - $28.48 $67,931 - $91,648	-3,218 Reduced 0.6%	536,173 $11.8 Million
Q1 2019 May 15, 2019	BUY	$24.76 - $31.66 $607,065 - $776,239	24,518 Added 4.76%	539,391 $14.8 Million
Q4 2018 Feb 14, 2019	BUY	$24.11 - $31.34 $625,172 - $812,646	25,930 Added 5.3%	514,873 $13.8 Million
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $285,257 - $378,898	-10,569 Reduced 2.12%	488,943 $14.3 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $285,050 - $589,529	16,748 Added 3.47%	499,512 $15.6 Million
Q1 2018 May 15, 2018	BUY	$19.9 - $32.25 $371,234 - $601,623	18,655 Added 4.02%	482,764 $9.61 Million
Q4 2017 Feb 14, 2018	BUY	$22.0 - $30.51 $10.2 Million - $14.2 Million	464,109	464,109 $13.5 Million

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.